mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.5 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.6 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.6 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.6 |